Literature DB >> 18205543

Liposomal amphotericin B as a cause of pseudohyperphosphatemia.

Daniel Mendoza, Sheila Connors, Clifford Lane, Sam Stehnach.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2008        PMID： 18205543     DOI： 10.1086/527041

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN： 1058-4838            Impact factor:   9.079


× No keyword cloud information.
  2 in total

1.  Hyperphosphatemia in pediatric oncology patients receiving liposomal amphotericin B.

Authors:  Chad A Knoderer; Holly M Knoderer
Journal:  J Pediatr Pharmacol Ther       Date:  2011-04

2.  Case-control study and case series of pseudohyperphosphatemia during exposure to liposomal amphotericin B.

Authors:  Nicole M Bohm; Katherine C Hoover; Amy E Wahlquist; Yusheng Zhu; Juan Carlos Q Velez
Journal:  Antimicrob Agents Chemother       Date:  2015-08-17       Impact factor: 5.191
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.